Overview

A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Status:
Recruiting
Trial end date:
2026-10-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the mavacamten impact on myocardial structure with cardiac magnetic resonance imaging (CMR) in adult participants with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) [New York Heart Association (NYHA) Functional Class II or III].
Phase:
Phase 4
Details
Lead Sponsor:
Bristol-Myers Squibb